In prostate cancer cohorts, UBA1 exhibited frequencies of copy number gain higher than 40%, and importantly, the copy number of UBA1 was strongly correlated with its mRNA expression (Fig. 1C; Supplementary Fig. S1B). This evidence concerns the gene UBA1 and prostate cancer.